HANGZHOU CITY, ZHEJIANG, CHINA, January 19, 2026 /EINPresswire.com/ -- With the development of the pharmaceutical and ...

A large share of medicines developed today may never reach patients for a surprisingly simple reason: they cannot dissolve well enough in water. For most treatments, the oral route remains the gold ...

A research team from Yale University in the U.S., in collaboration with global pharmaceutical company Boehringer Ingelheim, ...

Halo Pharma becomes a standalone drug product CDMO after the sale of Noramco’s API assets, adding sterile services by H2 2026 ...

By Maggie Fick and Michael Erman SAN FRANCISCO, Jan 26 (Reuters) - Artificial intelligence has yet to deliver on the most ...

Hank Green talks with us about why research and development make the prescription drug development process long...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

Find out how NAMs are influencing safety assessments and decision-making in the pharmaceutical industry ahead of 2026.

Under earlier rules, drugmakers had to get a test licence from CDSCO to manufacture small quantities of drugs for research, examination or analysis.

The FDA accepted an application for ivonescimab with chemotherapy for patients with lung cancer driven by EGFR changes after ...

BEIJING -- After years of dedicated research, a team of Chinese scientists has unveiled critical mechanisms governing early human embryonic development, offering novel theories and potential ...